Drug-pricing proposals: controls versus OTC reform

From over-the-counter drugs to employer-controlled health benefits, Cato's Michael Cannon and Dr. Jeffrey Singer argue that real health reform means giving patients control over their own money rather than reshuffling subsidies. They explain how freeing short-term plans, deregulating prescriptions, and ending tax favoritism for employer insurance could deliver lower prices, broader choice, and more durable reform than another round of federal spending.

---

Hosted on Acast. See acast.com/privacy for more information.